# NDA213170
> **NDA213170** · New Drug Application · Sponsor: LA JOLLA PHARMA · Approved 2020-05-29
## Drug
- **FDA Application Number:** NDA213170
- **Application type:** New Drug Application
- **Brand name:** —
- **Generic name:** —
- **Active ingredients:** —
- **Dosage form:** —
- **Route:** —
- **Marketing status:** —
- **Sponsor:** LA JOLLA PHARMA
- **First approval:** 2020-05-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213170)
---
*AI Analytics · CC0 1.0*